Armata Pharmaceuticals Inc (ARMP)
2.10
+0.01
(+0.48%)
USD |
NYAM |
Nov 21, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Total Liabilities (Quarterly): 149.21M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 149.21M |
| June 30, 2024 | 154.41M |
| March 31, 2024 | 176.87M |
| December 31, 2023 | 130.43M |
| September 30, 2023 | 125.15M |
| June 30, 2023 | 82.07M |
| March 31, 2023 | 86.33M |
| December 31, 2022 | 59.75M |
| September 30, 2022 | 47.30M |
| June 30, 2022 | 47.69M |
| March 31, 2022 | 46.23M |
| December 31, 2021 | 44.37M |
| September 30, 2021 | 18.92M |
| June 30, 2021 | 19.66M |
| March 31, 2021 | 18.83M |
| December 31, 2020 | 20.66M |
| September 30, 2020 | 21.06M |
| June 30, 2020 | 19.82M |
| March 31, 2020 | 10.62M |
| December 31, 2019 | 10.86M |
| September 30, 2019 | 11.17M |
| June 30, 2019 | 12.29M |
| Date | Value |
|---|---|
| March 31, 2019 | 4.656M |
| December 31, 2018 | 3.413M |
| September 30, 2018 | 3.766M |
| June 30, 2018 | 3.381M |
| March 31, 2018 | 3.109M |
| December 31, 2017 | 3.407M |
| September 30, 2017 | 4.024M |
| June 30, 2017 | 5.245M |
| March 31, 2017 | 7.654M |
| December 31, 2016 | 8.43M |
| September 30, 2016 | 7.808M |
| June 30, 2016 | 7.795M |
| March 31, 2016 | 19.36M |
| December 31, 2015 | 18.78M |
| September 30, 2015 | 18.42M |
| June 30, 2015 | 23.28M |
| March 31, 2015 | 41.68M |
| December 31, 2014 | 25.18M |
| September 30, 2014 | 17.08M |
| June 30, 2014 | 40.28M |
| March 31, 2014 | 58.46M |
| December 31, 2013 | 63.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.62M
Minimum
Mar 2020
176.87M
Maximum
Mar 2024
64.51M
Average
46.76M
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 10.68M |
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Electromed Inc | 7.427M |
| Xtant Medical Holdings Inc | 53.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.24M |
| Shareholders Equity (Quarterly) | -50.97M |